Search by Drug Name or NDC
NDC 80491-7850-03 QUVIVIQ 50 mg/1 Details
QUVIVIQ 50 mg/1
QUVIVIQ is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Idorsia Pharmaceuticals Ltd. The primary component is DARIDOREXANT.
MedlinePlus Drug Summary
Daridorexant is used to treat insomnia (difficulty falling asleep or staying asleep). Daridorexant is in a class of medications called orexin receptor antagonists. It works by blocking the action of a certain natural substance in the brain that causes wakefulness.
Related Packages: 80491-7850-03Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Daridorexant
Product Information
| NDC | 80491-7850 |
|---|---|
| Product ID | 80491-7850_4ee2df0f-c9f4-4b59-992c-0c2b838676c7 |
| Associated GPIs | 60500020100340 |
| GCN Sequence Number | 082965 |
| GCN Sequence Number Description | daridorexant HCl TABLET 50 MG ORAL |
| HIC3 | H2E |
| HIC3 Description | SEDATIVE-HYPNOTICS,NON-BARBITURATE |
| GCN | 51787 |
| HICL Sequence Number | 047751 |
| HICL Sequence Number Description | DARIDOREXANT HCL |
| Brand/Generic | Brand |
| Proprietary Name | QUVIVIQ |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Daridorexant |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/1 |
| Substance Name | DARIDOREXANT |
| Labeler Name | Idorsia Pharmaceuticals Ltd |
| Pharmaceutical Class | Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA] |
| DEA Schedule | CIV |
| Marketing Category | NDA |
| Application Number | NDA214985 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 80491-7850-03 (80491785003)
| NDC Package Code | 80491-7850-3 |
|---|---|
| Billing NDC | 80491785003 |
| Package | 1 BOTTLE in 1 CARTON (80491-7850-3) / 30 TABLET, FILM COATED in 1 BOTTLE |
| Marketing Start Date | 2022-04-07 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 15.7787 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | QUVIVIQ 50 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis